Very Early Onset (VEO) IBD: Multidisciplinary Evaluation and Precision Care at Cincinnati Children’s
Clinical Relevance
- Early identification of immune dysregulation or monogenic IBD may change treatment strategy.
- Multidisciplinary coordination reduces fragmented testing and delays in diagnosis.
- Precision-guided therapy can help avoid prolonged empiric treatment trials.
- Structured second opinion evaluations provide clarity for atypical or treatment-resistant disease.
Overview
Very early onset inflammatory bowel disease (VEO-IBD) represents a distinct clinical population with higher rates of severe disease, early therapy resistance, and immune-mediated or genetic etiologies. For many patients, standard pediatric IBD algorithms may not fully address underlying disease drivers.
Cincinnati Children’s VEO IBD Clinic is structured to provide coordinated, subspecialty evaluation in a single clinical pathway. Pediatric gastroenterologists experienced in early onset disease collaborate directly with immunology, genetics, pathology, dietetics, dermatology, radiology, surgery and social work. This integrated approach allows findings across disciplines to be reviewed together and incorporated into unified care planning.
Diagnostic Approach
For patients with early onset, atypical features, or refractory disease, the clinic incorporates targeted genetic and immune evaluation when indicated. These assessments can identify underlying immune dysfunction or monogenic variants that influence prognosis and treatment selection. Diagnostic testing is coordinated within the clinical visit to minimize redundancy.
Treatment Planning
Care plans are individualized and developed by the multidisciplinary team in collaboration with families. Treatment goals include disease control while supporting growth, nutritional status and developmental outcomes. Referring providers remain involved in longitudinal management when appropriate.
Referral and Second Opinion Support
The clinic serves as a resource for pediatric gastroenterologists seeking assistance with:
- IBD diagnosed before age 6
- Severe or refractory disease
- Atypical clinical or histologic features
- Concern for immune-based or monogenic disease
Timely evaluation is prioritized, and care recommendations are communicated directly back to referring teams.
Learn More / Refer
To discuss multidisciplinary co-management, diagnostic evaluation for suspected immune mediated or monogenic disease, or referral considerations for patients with very early onset IBD, contact the Cincinnati Children’s VEO IBD Clinic.
(Published April 2026)
